Pathological Complete Response in Neoadjuvant Treatment of Breast Cancer

被引：0
|
作者：
Patricia Cortazar
Charles E. Geyer
机构：
[1] U.S. Food and Drug Administration,Office of Hematology and Oncology Products, Center for Drug Evaluation and Research
[2] Virginia Commonwealth University,Massey Cancer Center
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Overall Survival; Trastuzumab; Lapatinib; Pertuzumab; Locally Advanced Breast Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1441 / 1446
页数：5
相关论文
共 50 条
  • [31] Prediction of pathological complete response by microRNA in breast cancer patients treated with neoadjuvant chemotherapy
    Shimomura, Akihiko
    Shiino, Sho
    Kawauchi, Junpei
    Takizawa, Satoko
    Ichikawa, Makiko
    Matsuzaki, Juntaro
    Sakamoto, Hiromi
    Kinoshita, Takayuki
    Tamura, Kenji
    Ochiya, Takahiro
    [J]. CANCER SCIENCE, 2018, 109 : 394 - 394
  • [32] Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response
    Blumencranz, P.
    Habibi, M.
    Treece, T.
    Blumencranz, L.
    Yoder, E.
    Audeh, W.
    Carter, E.
    McNaughton, L.
    Roussos, J.
    Shivers, S.
    Acs, G.
    Cox, C.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [33] Platelet predominant breast cancer is a new predictor for pathological complete response to neoadjuvant chemotherapy
    Ishikawa, Satoko
    Inokuchi, Masafumi
    Hayashi, Hironori
    Oyama, Katsunobu
    Nakagawara, Hisatoshi
    Miyashita, Tomoharu
    Tajima, Hidehiro
    Takamura, Hiroyuki
    Ninomiya, Itasu
    Kitagawa, Hirohisa
    Fushida, Sachio
    Fujimura, Takashi
    Ohta, Tetsuo
    [J]. CANCER RESEARCH, 2015, 75
  • [34] Complete pathological response following neoadjuvant chemotherapy in early breast cancer: a retrospective study
    Janjua, Tanzeel
    Ramanujam, Deivasikamani
    Mausam, Iqtedar
    Ali, Waqas
    Butt, Mohammad
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S127 - S127
  • [35] MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy
    Li, Yan-Ling
    Zhang, Xiao-Peng
    Li, Jie
    Cao, Kun
    Cui, Yong
    Li, Xiao-Ting
    Sun, Ying-Shi
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (02) : 242 - 249
  • [36] Clinical and Pathological Features of Breast Cancer Associated with the Pathological Complete Response to Anthracycline-Based Neoadjuvant Chemotherapy
    Keskin, Serkan
    Muslumanoglu, Mahmut
    Saip, Pinar
    Karanlik, Hasan
    Guveli, Murat
    Pehlivan, Esmehan
    Aydogan, Fatma
    Eralp, Yesim
    Aydiner, Adnan
    Yavuz, Ekrem
    Ozmen, Vahit
    Igci, Abdullah
    Topuz, Erkan
    [J]. ONCOLOGY, 2011, 81 (01) : 30 - 38
  • [37] Neoadjuvant epirubicin with or without sequential docetaxel in treatment of advanced breast cancer: assessment of pathological complete response and chemotherapy tolerability
    Ramirez-Torres, Nicolas
    Perez-Puentes, Ancizar
    Moctezuma-Meza, Christian
    Victoria-Ayala, Rosalia
    Ortiz-Rodriguez, Kenia
    Valenzuela-Martinez, Larissa A.
    Eugenia Ayala-Anzures, Maria
    [J]. CIRUGIA Y CIRUJANOS, 2019, 87 (01): : 59 - 68
  • [38] Predictors of Pathological Complete Response in Women with Clinical Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma
    Resende, Uanderson
    Cabello, Cesar
    Botelho Ramalho, Susana Oliveira
    Zeferino, Luiz Carlos
    [J]. ONCOLOGY, 2018, 95 (04) : 229 - 238
  • [39] Clinical and oncological results of the pathological complete response in rectal cancer after neoadjuvant treatment
    Codina Cazador, Antonio
    Farres Coll, Ramon
    Olivet Pujol, Francesc
    Martin Grillo, Adam
    Pujadas de Palol, Marcel
    Gomez Romeu, Nuria
    Julia Bergkvist, David
    Ortiz Duran, Rosa
    Diez Gomez, Ester
    [J]. CIRUGIA ESPANOLA, 2013, 91 (07): : 417 - 423
  • [40] Predictive factors associated with complete pathological response after neoadjuvant treatment for rectal cancer
    Hajer, J.
    Rim, A.
    Ghorbel, A.
    Amani, Y.
    Ines, L.
    Asma, B.
    Chiraz, N.
    [J]. CANCER RADIOTHERAPIE, 2021, 25 (03): : 259 - 267
12345